Notably, increasing age has classically been associated with a poor prognosis in gliomas and patients with IDH wild-type tumors are significantly older than those with IDH-mutated tumors, which is consistent with the results of the present study (Table I) (2,3,5,7). The gene discussed is IDH2; the disease is central nervous system cancer.